Arnado, Lorenzo, Jr. C.
HRN: 09-66-46 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/12/2025
06/18/2025
IV
500mg
Q8
Inguinal Hernia
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes